LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home ...
Once-daily asundexian 50 mg, on top of antiplatelet therapy, reduced risk for recurrent ischemic stroke after a ...
1don MSN
New protocol for Treg expansion uses targeted immunotherapy to reduce transplant complications
In preclinical studies, researchers found that priming the immune system with a Treg-expanding therapy before stem cell ...
AI-Stroke, a France-based Software-as-a-Medical-Device (SaMD) company using artificial intelligence (AI) to develop an “ ...
Patients with symptomatic intracranial atherosclerosis who show impaired distal perfusion face a significantly higher risk for early stroke recurrence.
In this video, Rebecca Saff, MD, PhD, allergy/immunology fellowship director and assistant physician at Massachusetts General ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback